Atlas Trials

A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Clinical trial NCT07688187 · RECRUITING

Trial details

NCT number
NCT07688187
Sponsor
PeptiDream Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Clear Cell Renal Cell Carcinoma
Start date
2026-06-01
Primary completion
2029-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.